Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals

Status:
Active, not recruiting

Trial end date:
2022-03-31

Target enrollment:

Participant gender:

The objective of our study is to demonstrate safety and immunogenicity of COVID-19 preventive DNA vaccine in elderly individuals.

Phase 1

Genexine, Inc.